CYFIP2 and early-onset autosomal dominant Alzheimer disease: We suggest that CYFIP2 expression decreases already in the early stages of Alzheimer’s disease, as we found an ∼2-fold reduction in mild Alzheimer’s disease hippocampus (Braak stages I–II).